159 related articles for article (PubMed ID: 15295351)
21. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
Kaufman RH; Adam E; Icenogle J; Lawson H; Lee N; Reeves KO; Irwin J; Simon T; Press M; Uhler R; Entman C; Reeves WC
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):87-92. PubMed ID: 9024095
[TBL] [Abstract][Full Text] [Related]
22. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
[TBL] [Abstract][Full Text] [Related]
23. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
24. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
25. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
26. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
27. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection.
Schneider A; Zahm DM; Kirchmayr R; Schneider VL
Am J Obstet Gynecol; 1996 May; 174(5):1534-41. PubMed ID: 9065125
[TBL] [Abstract][Full Text] [Related]
28. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
29. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
30. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the Costs of Invasive Cervical Cancer Treatment in Brazil: A Micro-Costing Study.
Santos CL; Souza AI; Figueiroa JN; Vidal SA
Rev Bras Ginecol Obstet; 2019 Jun; 41(6):387-393. PubMed ID: 31247667
[TBL] [Abstract][Full Text] [Related]
33. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
Legood R; Gray A; Wolstenholme J; Moss S
BMJ; 2006 Jan; 332(7533):79-85. PubMed ID: 16399769
[TBL] [Abstract][Full Text] [Related]
34. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
[TBL] [Abstract][Full Text] [Related]
35. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
36. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.
Melnikow J; Kulasingam S; Slee C; Helms LJ; Kuppermann M; Birch S; McGahan CE; Coldman A; Chan BK; Sawaya GF
Obstet Gynecol; 2010 Nov; 116(5):1158-70. PubMed ID: 20966702
[TBL] [Abstract][Full Text] [Related]
37. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears.
Wright TC; Lorincz A; Ferris DG; Richart RM; Ferenczy A; Mielzynska I; Borgatta L
Am J Obstet Gynecol; 1998 May; 178(5):962-6. PubMed ID: 9609567
[TBL] [Abstract][Full Text] [Related]
38. Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus.
García-Carrasco M; Mendoza-Pinto C; Méndez-Martínez S; Rodríguez-Reyes A; Munguía-Realpozo P; Taboada-Cole A; Vallejo-Ruiz V; Etchegaray-Morales I; Jiménez-Herrera R; Juárez-Melchor D; Villanueva-López I
Lupus; 2020 Aug; 29(9):1060-1066. PubMed ID: 32501171
[TBL] [Abstract][Full Text] [Related]
39. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia.
Petry KU; Böhmer G; Iftner T; Davies P; Brummer O; Kühnle H
Am J Obstet Gynecol; 2002 Jan; 186(1):28-34. PubMed ID: 11810080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
